BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) | RFA MH 19 400

Opportunity Information: Apply for RFA MH 19 400

The National Institutes of Health (NIH) issued this grant opportunity under the BRAIN Initiative to fund research that examines the ethical implications of rapid advances in neurotechnology and brain science. Listed as RFA-MH-19-400, it uses the R01 research project grant mechanism and is labeled "Clinical Trial Optional," meaning applicants may propose studies that include a clinical trial if it is appropriate for the ethical questions being investigated, but a clinical trial is not required. The announcement is positioned within the broader BRAIN Initiative agenda, which is designed to accelerate transformative discoveries about how the human brain works. In this specific FOA, the emphasis is not on building the next neural device or producing a new neuroscience dataset for its own sake, but on addressing the core ethical issues that arise because those scientific and technological breakthroughs are happening quickly and are increasingly capable, scalable, and impactful.

The FOA is guided by the BRAIN Initiative's long-term plan, "BRAIN 2025: A Scientific Vision." In practical terms, NIH is looking for research that helps anticipate, clarify, and resolve ethical challenges that come with emerging tools and approaches in brain research, especially those supported or enabled by BRAIN-funded advances. The opportunity explicitly encourages work that can be complementary and integrative with ongoing neuroscience efforts, meaning the strongest projects will often connect directly to real-world research practices and technology trajectories rather than treating ethics as an abstract add-on. The goal is to generate evidence, frameworks, and actionable guidance that can inform researchers, clinicians, institutional review boards, technology developers, policymakers, and communities affected by neurotechnology.

Although the FOA text provided here does not list specific topic areas, the scope implied by "ethical implications of advancements in neurotechnology and brain science" typically includes questions such as mental privacy and the governance of neural data; informed consent challenges when technologies are complex, novel, or used with populations that may be vulnerable; risks and benefits of invasive or semi-invasive neural interfaces; responsible communication about capabilities and limitations of neurotechnologies; fairness, bias, and equitable access to emerging interventions; ownership and control of neural recordings and derived biomarkers; appropriate boundaries between clinical care, research, enhancement, and consumer uses; and broader social implications of technologies that can measure, decode, or modulate brain activity. Projects responsive to this FOA would be expected to move beyond commentary by using rigorous methods from bioethics, law, social science, neuroscience, clinical research, and related fields to produce findings that can actually guide practice.

Administratively, this is a discretionary grant program administered by NIH, falling under broad federal activity categories that include education, health, and social services. Multiple CFDA numbers are associated with the opportunity (93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866), reflecting NIH's structure across institutes and programs that may participate in funding or oversight. The award ceiling listed is $300,000, indicating an upper bound for requested support as represented in the source data. The original closing date in the record is October 9, 2020, and the FOA creation date is October 18, 2018, which places this announcement in the context of the BRAIN Initiative's earlier waves of ethics-focused funding.

Eligibility is broad and includes many types of U.S. governmental units (state, county, city or township governments, special district governments), independent school districts, and public housing authorities/Indian housing authorities. It also includes public and state-controlled institutions of higher education, private institutions of higher education, and a wide range of nonprofit organizations, whether they have 501(c)(3) status or not. For-profit organizations are eligible as well (other than small businesses and including small businesses), and tribal entities are specifically included both as federally recognized Native American tribal governments and as Native American tribal organizations that are not federally recognized tribal governments. In addition, the FOA highlights other eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This wide eligibility signals NIH interest in ethical research that is multidisciplinary and also grounded in diverse institutional settings and community perspectives, including those historically underrepresented in biomedical research.

Overall, this grant opportunity is meant to strengthen the ethical foundation of modern brain science by supporting research that keeps pace with neurotechnology innovation. The intent is to fund projects that produce practical, evidence-informed insights into how emerging brain technologies should be developed, tested, governed, and communicated in ways that respect individuals, protect communities, and maximize societal benefit while minimizing harm.

• The National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866.
• This funding opportunity was created on 2018-10-18.
• Applicants must submit their applications by 2020-10-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $300,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA MH 19 400

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: